Quick Answer
CONMED Corp reported Operating Income Loss of $102.62 million for the year ending 2025.
- CONMED Corp showed a decrease of -48.8% in Operating Income Loss from 2024 to 2025.
- This data is from CONMED Corp's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $14.78 million | Q3 2010: $15.20 million | Q1 2011: $17.26 million | Q2 2011: $16.70 million | Q3 2011: $15.94 million | Q1 2012: $17.02 million | Q2 2012: $17.06 million | Q3 2012: $14.11 million | Q1 2013: $15.87 million | Q2 2013: $15.65 million | Q3 2013: $8.81 million | Q1 2014: $17.31 million | Q2 2014: $15.94 million | Q3 2014: $2.45 million | Q1 2015: $10.95 million | Q2 2015: $12.42 million | Q3 2015: $14.84 million | Q1 2016: $3.54 million | Q2 2016: $7.68 million | Q3 2016: $13.85 million | Q1 2017: -$2.49 million | Q2 2017: $12.78 million | Q3 2017: $13.47 million | Q1 2018: $17.28 million | Q2 2018: $16.68 million | Q3 2018: $11.52 million | Q1 2019: $11.64 million | Q2 2019: $18.66 million | Q3 2019: $20.94 million | Q1 2020: $13.17 million | Q2 2020: -$21.25 million | Q3 2020: $29.38 million | Q1 2021: $20.08 million | Q2 2021: $25.71 million | Q3 2021: $26.71 million | Q1 2022: $22.44 million | Q2 2022: $24.46 million | Q3 2022: $24.25 million | Q1 2023: $12.70 million | Q2 2023: $27.42 million | Q3 2023: $30.30 million | Q1 2024: $35.01 million | Q2 2024: $47.11 million | Q3 2024: $65.71 million | Q1 2025: $15.96 million | Q2 2025: $38.16 million | Q3 2025: $11.88 million.
- Over the full 17 years of available data (2009 to 2025), CONMED Corp's Operating Income Loss has grown by 263.0%.
- Historical annual values: Fiscal year 2025: $102.62 million | Fiscal year 2024: $200.33 million | Fiscal year 2023: $120.60 million | Fiscal year 2022: $70.05 million | Fiscal year 2021: $109.72 million | Fiscal year 2020: $46.01 million | Fiscal year 2019: $79.11 million | Fiscal year 2018: $71.31 million | Fiscal year 2017: $46.94 million | Fiscal year 2016: $37.68 million | Fiscal year 2015: $51.18 million | Fiscal year 2014: $52.79 million | Fiscal year 2013: $56.51 million | Fiscal year 2012: $65.21 million | Fiscal year 2011: $8.27 million | Fiscal year 2010: $57.09 million | Fiscal year 2009: $28.27 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: